Global Antibody Therapeutics and Blood Antibody Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Antibody Therapeutics and Blood Antibody Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.



Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.

According to our (Global Info Research) latest study, the global Antibody Therapeutics and Blood Antibody Therapeutics market size was valued at US$ 218110 million in 2023 and is forecast to a readjusted size of USD 413240 million by 2030 with a CAGR of 9.7% during review period.

The industry"s leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.

This report is a detailed and comprehensive analysis for global Antibody Therapeutics and Blood Antibody Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts, in consumption value ($ Million), 2019-2030

Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Antibody Therapeutics and Blood Antibody Therapeutics market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Antibody Therapeutics and Blood Antibody Therapeutics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Antibody Therapeutics and Blood Antibody Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbvie, Johnson & Johnson, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda, Amgen, Biogen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Antibody Therapeutics and Blood Antibody Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Antibody Therapeutics and Blood Antibody Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
IgG1
IgG4
Others

Market segment by Application
Autoimmune
Tumor
Others

Market segment by players, this report covers
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Antibody Therapeutics and Blood Antibody Therapeutics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Antibody Therapeutics and Blood Antibody Therapeutics, with revenue, gross margin, and global market share of Antibody Therapeutics and Blood Antibody Therapeutics from 2019 to 2024.

Chapter 3, the Antibody Therapeutics and Blood Antibody Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibody Therapeutics and Blood Antibody Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Therapeutics and Blood Antibody Therapeutics.

Chapter 13, to describe Antibody Therapeutics and Blood Antibody Therapeutics research findings and conclusion.